Literature DB >> 7924744

Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis.

M Wegener1, R J Adamek, B Wedmann, M Jergas, P Altmeyer.   

Abstract

Liquid esophageal transit and gastric emptying, mouth-to-cecum transit, and whole gut transit of a solid-liquid meal were measured in 14 patients with PSS, 16 control subjects (esophageal transit), and 20 control subjects (gastrointestinal transit), respectively, by using scintigraphic techniques, the hydrogen breath test, and stool markers. In patients with PSS, the glucose hydrogen breath test for detection of small intestinal overgrowth was performed and various gastrointestinal symptoms were determined. Esophageal transit and gastric emptying were significantly prolonged in PSS patients with 11 of 14 PSS patients (79%) disclosing delayed esophageal transit and eight of 14 PSS patients (57%) disclosing delayed gastric emptying. All PSS patients with prolonged gastric emptying also had delayed esophageal transit and there was a significant positive correlation between esophageal transit and gastric emptying (r = 0.696, P < 0.01). No significant differences between PSS patients and controls were detected concerning mouth-to-cecum transit and whole gut transit, but abnormally delayed mouth-to-cecum transit was found in four of 10 PSS patients (40%) and abnormally prolonged whole gut transit was detected in three of 13 PSS patients (23%). Small bacterial overgrowth was diagnosed in three of 14 PSS patients (21%). Delayed esophageal transit and gastric emptying were associated with dysphagia, retrosternal pain, and epigastric fullness, while prolonged whole gut transit was associated with constipation. It is concluded that delayed gastric emptying is frequently associated with esophageal transit disorders in PSS patients and may be one important factor for the development of gastroesophageal reflux disease in these patients.

Entities:  

Mesh:

Year:  1994        PMID: 7924744     DOI: 10.1007/bf02090373

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  29 in total

1.  Gastric emptying and interdigestive antroduodenal motility in patients with esophageal scleroderma.

Authors:  M Bortolotti; E Turba; A Tosti; P Sarti; F Brunelli; L Del Campo; L Barbara
Journal:  Am J Gastroenterol       Date:  1991-06       Impact factor: 10.864

2.  Gastrointestinal transit of solid-liquid meal in chronic alcoholics.

Authors:  M Wegener; J Schaffstein; U Dilger; C Coenen; B Wedmann; G Schmidt
Journal:  Dig Dis Sci       Date:  1991-07       Impact factor: 3.199

3.  Prolonged clearance is the primary abnormal reflux parameter in patients with progressive systemic sclerosis and esophagitis.

Authors:  J R Murphy; P McNally; P Peller; S S Shay
Journal:  Dig Dis Sci       Date:  1992-06       Impact factor: 3.199

4.  Esophageal manometry and pH-probe monitoring in the evaluation of gastroesophageal reflux in patients with progressive systemic sclerosis.

Authors:  P Stentoft; L Hendel; S Aggestrup
Journal:  Scand J Gastroenterol       Date:  1987-05       Impact factor: 2.423

5.  Esophageal dysfunction and radionuclide transit in progressive systemic sclerosis.

Authors:  A Akesson; T Gustafson; F Wollheim; J Brismar
Journal:  Scand J Rheumatol       Date:  1987       Impact factor: 3.641

6.  Interdigestive motor activity in patients with systemic sclerosis.

Authors:  W D Rees; R J Leigh; N D Christofides; S R Bloom; L A Turnberg
Journal:  Gastroenterology       Date:  1982-09       Impact factor: 22.682

7.  Gastric emptying in patients with gastroesophageal reflux.

Authors:  R W McCallum; D M Berkowitz; E Lerner
Journal:  Gastroenterology       Date:  1981-02       Impact factor: 22.682

8.  The gastrointestinal manifestations of scleroderma: pathogenesis and management.

Authors:  S Cohen
Journal:  Gastroenterology       Date:  1980-07       Impact factor: 22.682

9.  Radionuclide transit studies in the detection of oesophageal dysmotility.

Authors:  J N Blackwell; W J Hannan; R D Adam; R C Heading
Journal:  Gut       Date:  1983-05       Impact factor: 23.059

10.  Abnormal colonic motility in progressive systemic sclerosis.

Authors:  W M Battle; W J Snape; S Wright; M A Sullivan; S Cohen; A Meyers; R Tuthill
Journal:  Ann Intern Med       Date:  1981-06       Impact factor: 25.391

View more
  22 in total

Review 1.  Gastroparesis: pathogenesis, diagnosis and management.

Authors:  William L Hasler
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2011-07-19       Impact factor: 46.802

Review 2.  Pharmacotherapy of systemic sclerosis.

Authors:  Arnold E Postlethwaite; L Jeff Harris; Syed H Raza; Swapna Kodura; Titilola Akhigbe
Journal:  Expert Opin Pharmacother       Date:  2010-04       Impact factor: 3.889

Review 3.  Prevalence and predictors of small intestinal bacterial overgrowth in systemic sclerosis: a systematic review and meta-analysis.

Authors:  Xin Feng; Xiao-Qing Li; Zheng Jiang
Journal:  Clin Rheumatol       Date:  2021-01-11       Impact factor: 2.980

4.  Small intestinal bacterial overgrowth: a comprehensive review.

Authors:  Andrew C Dukowicz; Brian E Lacy; Gary M Levine
Journal:  Gastroenterol Hepatol (N Y)       Date:  2007-02

5.  Characterization of gastric myoelectrical rhythms in patients with systemic sclerosis using multichannel surface electrogastrography.

Authors:  Terry McNearney; Xuemei Lin; Jharana Shrestha; Jeffrey Lisse; J D Z Chen
Journal:  Dig Dis Sci       Date:  2002-04       Impact factor: 3.199

6.  Measurement and evaluation of gastric emptying using radiopaque barium markers.

Authors:  K Kikuchi; M Kusano; O Kawamura; M Mori; T Sekiguchi
Journal:  Dig Dis Sci       Date:  2000-02       Impact factor: 3.199

7.  Gastric dysmotility after liquid bolus ingestion in systemic sclerosis: an ultrasonographic study.

Authors:  Franco Cozzi; Giancarlo Parisi; Luca Ciprian; Arianna Bullo; Silvia Cardarelli; Michela Rizzo; Paolo Sfriso; Leonardo Punzi
Journal:  Rheumatol Int       Date:  2011-01-22       Impact factor: 2.631

8.  Nausea, bloating and abdominal pain in the Roux-en-Y gastric bypass patient: more questions than answers.

Authors:  G Anton Decker; John K DiBaise; Jonathan A Leighton; James M Swain; Michael D Crowell
Journal:  Obes Surg       Date:  2007-11       Impact factor: 4.129

Review 9.  Points to consider for clinical trials of the gastrointestinal tract in systemic sclerosis.

Authors:  Daniel E Furst; Yolanda Braun-Moscovic; Dinesh Khanna
Journal:  Rheumatology (Oxford)       Date:  2017-09-01       Impact factor: 7.580

Review 10.  Gastrointestinal manifestations of systemic sclerosis.

Authors:  Robyn Domsic; Kenneth Fasanella; Klaus Bielefeldt
Journal:  Dig Dis Sci       Date:  2007-10-13       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.